Table 3. Susceptibility profile of E. coli, other uropathogens, ESBL producing isolates.
| Antibiotic agents | E. coli isolates n = 107/141 (75.9%) | Other uropathogens isolates n = 34/141 (24.1%) | ESBL producing isolates n = 14/141 (9.9%) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Susceptibilitya n (%) | S | I | R | S | I | R | S | I | R |
| Amoxicillin | 84 (78.5%) | 21 (19.6%) | 2 (1.9%) | 32 (94.1%) | 1 (2.9%) | 1 (2.9%) | 6 (42.9%) | 8 (57.1%) | 0 (0%) |
| Ampicillin | 41 (38.3%) | 2 (1.9%) | 64 (59.8%) | 16 (47.1%) | 0 (0%) | 18 (52.9%) | 0 (0%) | 0 (0%) | 14 (100%) |
| Ciprofloxacin | 82 (76.6%) | 0 (0%) | 25 (23.4%) | 31 (91.2%) | 3 (8.8%) | 0 (0%) | 5 (35.7%) | 1 (7.1%) | 8 (57.1%) |
| Co-trimoxazole | 73 (68.2%) | 0 (0%) | 34 (31.8%) | 30 (88.2%) | 0 (0%) | 4 (11.8%) | 5 (35.7%) | 0 (0%) | 9 (64.3%) |
| Gentamicin | 80 (74.8%) | 0 (0%) | 27 (25.2%) | 30 (88.2) | 2 (5.9%) | 2 (5.9%) | 8 (57.1%) | 0 (0%) | 6 (42.9%) |
| Nitrofurantoin | 105 (98.1%) | 1 (0.9%) | 1 (0.9%) | 25 (73.5%) | 6 (17.6%) | 3 (8.8%) | 12 (85.7%) | 0 (0%) | 2 (14.3%) |
aS = sensitive; I = intermediate, R = resistant.